Acute myelomonocytic leukemia

Acute myelomonocytic leukemia is an aggressive subtype of acute myeloid leukemia characterized by the neoplastic proliferation of both granulocytic and monocytic precursor cells in the bone marrow and peripheral blood Pathophysiologically, the condition is defined by elevated blast counts with significant dual differentiation, where both neutrophilic lineage cells and monocytic lineage cells each comprise at least 20% of bone marrow leukocytes

Acute myelomonocytic leukemia is an aggressive subtype of acute myeloid leukemia characterized by the neoplastic proliferation of both granulocytic and monocytic precursor cells in the bone marrow and peripheral blood

Acute myelomonocytic leukemia is an aggressive subtype of acute myeloid leukemia characterized by the neoplastic proliferation of both granulocytic and monocytic precursor cells in the bone marrow and peripheral blood Patients frequently demonstrate extramedullary tissue infiltration—including gingival hyperplasia, hepatosplenomegaly, and skin involvement—driven by the intrinsic tissue-migratory properties of the leukemic monocytic lineage

Primarily affecting adults, this hematologic malignancy disrupts normal hematopoiesis, leading to severe cytopenias that clinically manifest as fatigue, susceptibility to recurrent infections, and bleeding diatheses

Primarily affecting adults, this hematologic malignancy disrupts normal hematopoiesis, leading to severe cytopenias that clinically manifest as fatigue, susceptibility to recurrent infections, and bleeding diatheses Pathophysiologically, the condition is defined by elevated blast counts with significant dual differentiation, where both neutrophilic lineage cells and monocytic lineage cells each comprise at least 20% of bone marrow leukocytes

Pathophysiologically, the condition is defined by elevated blast counts with significant dual differentiation, where both neutrophilic lineage cells and monocytic lineage cells each comprise at least 20% of bone marrow leukocytes

Patients frequently demonstrate extramedullary tissue infiltration—including gingival hyperplasia, hepatosplenomegaly, and skin involvement—driven by the intrinsic tissue-migratory properties of the leukemic monocytic lineage